The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects

Eye

Volumn 14, Issue 2, 2000, Pages 206-210

  Aragona, Pasquale ^a   Tripodi, Giuliana ^a   Spinella, Rosaria ^a   Laganà, Emilia ^a   Ferreri, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Corneal sensitivity; Diclofenac; Flurbiprofen; Indomethacin; Ketorolac; Non steroidal anti inflammatory drugs

Indexed keywords

DICLOFENAC; FLUORESCEIN; FLURBIPROFEN; INDOCOLLIRIO; INDOMETACIN; KETOROLAC; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; NOVESINA; OXYBUPROCAINE; PLACEBO;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CORNEA EPITHELIUM; CORNEA SENSIBILITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SIDE EFFECT; TISSUE INJURY; VITAL STAIN;

EID: 0034065814     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.2000.55     Document Type: Article

References (34)

1. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992;36:259-84.
2. Gwon A, Vaughan ER, Cheetham JK, De Gryse. Ocufen (Flurbiprofen) in the treatment of ocular pain after radial keratotomy. CLAO J 1994;20:131-8.
3. Arshinoff S, D'Addario D, Sadler C, Bilotta R, Johnson TM. Use of topical non-steroidal antiinflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994;20 (Suppl):216-22.
4. Millodot M. The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci 1977;16:240-2.
5. Riss B, Binder S, Riss P, Kemeter P. Corneal sensitivity during the menstrual cycle. Br J Ophthalmol 1982;66:123-6.
6. Kodama T, Hayasaka S, Setogawa T. Immunofluorescent staining and corneal sensitivity in patients suspected of having herpes simplex keratitis. Am J Ophthalmol 1992;113:187-9.
7. McNamara NA, Brand RJ, Polse KA, Bourne WM. Corneal function during normal and high serum glucose levels in dibetes. Invest Ophthalmol Vis Sci 1998;39:3-17.
8. Martin XY, Sapran AB. Corneal hypoesthesia. Surv Ophthalmol 1988;33:28-40.
9. Koenig SB, Berkowitz RA, Beuerman RW, McDonald MB. Corneal sensitivity after epikeratophakia. Ophthalmology 1983;90:1213-8.
10. Shivitz IA, Arrowsmith PN. Corneal sensitivity after radial keratotomy. Ophthalmology 1988;95:87-32.
11. Campos M, Hertzog L, Garbus JJ, McDonnell PJ. Corneal sensitivity after photorefractive keratectomy. Am J Ophthalmol 1992;114:51-4.
12. Loya N, Bassage S, Vyas S, del Cerro M, Park SB, Aquavella JV. Topical diclofenac following excimer laser: effect on corneal sensitivity and wound healing in rabbits. J Refract Corneal Surg 1994;10:423-7.
13. Szerenyi K, Sorken K, Garbus J, Lee M, McDonnell PJ. Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 1994;118:312-5.
14. Zaidman GW. Diclofenac and its effect on corneal sensation. Arch Ophthalmol 1995;113:262.
15. Aragona P, Fragalà I, Oteri FC, Battaglia F, Ferreri G. Effect of the topical administration of diclofenac sodium and indomethacin on corneal sensitivity in normal subjects. Vision Res 1995;35 (Suppl):S146.
16. Insel PA. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:638-81.
17. Buckley MM, Brogden RN. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990;39:86-109.
18. Lemp MM. Report of the National Eye Institute/Industry workshop on clinical trials in dry eye. CLAO J 1995;21:221-32.
19. Cochet P, Bonnet R. L'esthesie cornéenne. Clin Ophthalmol 1960;4:3-27.
20. Laitinen J, Nuutinen L, Kiiskila EL, Freudental Y, Ranta P, et al. Comparison of intravenous diclofenac, indomethacin and oxycodone as post-operative analgesics in patients undergoing knee surgery. Eur J Anaesth 1992;9:29-34.
21. Bellamy N, Bensen WG, Ford PM, Huang SH, Lang JY. Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. Clin Invest Med 1992;15:427-33.
22. Toscani F, Piva L, Corli O, Gallucci M, Speranza R, Tamburini M, De Conno F, Ventafridda V. Ketorolac versus diclofenac sodium in cancer pain. Arzneimittelforschung 1994;44:550-4.
23. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1988;35:244-85.
24. Martini A, Bondiolotti GP, Sarcerdote P, Pierro L, Picotto GB, et al. Diclofenac increases beta-endorphins plasma concentrations. J Int Med Res 1984;12:92-5.
25. Rainsford KD. The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side-effects. In: Rainsford KD, editor. Azapropazone: 20 years of clinical use. Lancaster: Kluwer Academic, 1989:31-52.
26. Chen X, Gallar J, Belmonte C. Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibres to chemical irritation. Invest Ophthalmol Vis Sci 1997;38:1944-53.
27. McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesics efficacy. Drugs 1991;41:533-47.
28. Ellis PP, Pfoff DS, Bloedow DC, Riegel M. Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. J Ocul Pharmacol 1994;10:677-82.
29. Frangouli A, Shah S, Chatterjee A, Morgan PB, Kinsey J. Efficacy of topical nonsteroidal drops as pain relief after excimer laser photorefractive keratectomy. J Refract Surg 1998;14(2 Suppl):S207-8.
30. Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol 1997;115:1119-22.
31. Shimazaki J, Saito H, Yang HY, Toda I, Fujishima H, Tsubota K. Persistent epithelial defects following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea 1995;16:623-7.
32. Assouline M, Renard G, Arne JL, David T, Lasmolles C, Malecaze F, Pouliquen YJ. Prospective randomized trial of topical soluble 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. Ophthalmic Surg Lasers 1998;29:365-74.
33. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997;13:158-61.
34. Seitz B, Sorken K, LaBree LD, Garbus JJ, McDonnell PJ. Corneal sensitivity and burning sensation. Arch Ophthalmol 1996;114:921-4.